Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-13

Clinical Trial Update: Fecal Microbial Transplantation in Treatment of Irritable Bowel Syndrome; a Double Blinded Placebo Controlled Trial. [Phase 2]

View source ↗

Summary

Phase 2 double-blind, placebo-controlled trial evaluating fecal microbiota transplantation for irritable bowel syndrome has completed. The study was conducted b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal Microbial Transplantation (fecal microbiota transplantation)

Snippet

Sponsor: University Hospital of North Norway | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED